<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>0864-3466</journal-id>
<journal-title><![CDATA[Revista Cubana de Salud Pública]]></journal-title>
<abbrev-journal-title><![CDATA[Rev Cubana Salud Pública]]></abbrev-journal-title>
<issn>0864-3466</issn>
<publisher>
<publisher-name><![CDATA[Editorial Ciencias Médicas]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S0864-34662020000100005</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Trastornos lipídicos en pacientes hispanoamericanos en el primer nivel de atención sanitaria de Lima, Perú]]></article-title>
<article-title xml:lang="en"><![CDATA[Lipid disorders in Hispanic Americans patients in the primary health care level in Lima, Peru]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Moya-Salazar]]></surname>
<given-names><![CDATA[Jeel]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
<xref ref-type="aff" rid="Aaf"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Pio-Dávila]]></surname>
<given-names><![CDATA[Liz]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Hospital Nacional Docente Madre Niño San Bartolomé Servicio de Patología clínica ]]></institution>
<addr-line><![CDATA[Lima ]]></addr-line>
<country>Perú</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,Centro de atención primaria Policlínico La Fe Servicio de Laboratorio clínico ]]></institution>
<addr-line><![CDATA[Lima ]]></addr-line>
<country>Perú</country>
</aff>
<aff id="Af3">
<institution><![CDATA[,Universidad Norbert Wiener Facultad de Ciencias de la Salud Escuela de Medicina Humana]]></institution>
<addr-line><![CDATA[Lima ]]></addr-line>
<country>Perú</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>03</month>
<year>2020</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>03</month>
<year>2020</year>
</pub-date>
<volume>46</volume>
<numero>1</numero>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_arttext&amp;pid=S0864-34662020000100005&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_abstract&amp;pid=S0864-34662020000100005&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_pdf&amp;pid=S0864-34662020000100005&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[RESUMEN  Introducción:  Las dislipidemias constituyen un factor de riesgo para el desarrollo de las enfermedades cardiovasculares, las que se consideran la principal causa de muerte a nivel mundial.  Objetivos:  Evaluar los trastornos lipídicos en pacientes hispanoamericanos en el primer nivel de atención sanitaria de Lima.  Métodos:  En el periodo de 2015-2016 se realizó una investigación prospectiva en 117 pacientes del Servicio de Laboratorio Clínico, Policlínico La Fe en Lima. Se tuvieron en cuenta las guías National Cholesterol Education Program Adult Treatment Panel III (NCEP ATP III), US Preventive Services Task Force y la guía de práctica clínica del Instituto Mexicano del Seguro Social. De acuerdo con cada guía se establecieron las variables lipídicas: triglicéridos (TG) elevados (TG &#8805; 150 mg/dl) y colesterol total elevado (CT &#8805; 200 mg/dl), colesterol LDL-C elevado (LDL-C &#8805; 130 mg/dl) y HDL-C disminuido (HDL-C &#8804; 40 mg/dl).  Resultados:  El 71 % de los pacientes presentaron HDL-C disminuido, el 41 % hipertriacilgliceridemia, el 35,9 % hipercolesterolemia y el 33,3 % LDL-C elevado. Según la guía US Preventive Services Task Force se determinaron 9 pacientes con dislipidemia grado B, por la guía National Cholesterol Education Program Adult Treatment Panel III (NCEP ATP III), 99 pacientes en 4 grupos de dislipidemia y 5 pacientes sin trastornos lipídicos según la guía de práctica clínica del Instituto Mexicano del Seguro Social.  Conclusiones: Se observa una alta frecuencia de pacientes con trastornos lípidos principalmente por HDL-C disminuido y se evidencia las ventajas de la guía de práctica clínica en el primer nivel de atención sanitaria.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[ABSTRACT  Introduction:  Dyslipidemia is a risk factor for the development of cardiovascular diseases, which are considered to be the main cause of death at the global level.  Objectives:  To assess lipid disorders in Hispanic Americans patients in the primary health care level in Lima.  Methods:  In the period 2015-2016 a prospective research was made in 117 patients of the Service of Clinical Laboratory, La Fe Policlinic in Lima. There were used the guides named National Cholesterol Education Program Adult Treatment Panel III (NCEP ATP III), US Preventive Services Task Force, and the clinical practice guidelines of the Mexican Institute of Social Security. The lipid variables were established in accordance with each guide: High Triglycerides (TG) (TG &#8805;150 mg/dl) and high total cholesterol (CT &#8805; 200 mg/dl), High LDL-C cholesterol (LDL-C &#8805; 130 mg/dl) and decreased HDL-C (HDL-C &#8804; 40 mg/dl).  Results:  71 % of the patients presented decreased HDL-C, 41 % hypertriacilglyceridemia, 35.9 % hypercholesterolemia and 33.3 % high LDL-C. According to the US Preventive Services Task Force guide 9 patients with dyslipidemia grade B were identified by the National Cholesterol Education Program Adult Treatment Panel III (NCEP ATP III) guide, and 99 patients in 4 groups of dyslipidemia and 5 patients without lipid disorders were identified according to the clinical practice guidelines of the Mexican Institute of Social Security.  Conclusions:  It is observed a high frequency of patients with lipid disorders mainly by decreased HDL-C and there is evidence of the advantages of the clinical practice guidelines in the primary level of health care.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[dislipidemia]]></kwd>
<kwd lng="es"><![CDATA[HDL]]></kwd>
<kwd lng="es"><![CDATA[colesterol]]></kwd>
<kwd lng="es"><![CDATA[lípidos]]></kwd>
<kwd lng="es"><![CDATA[triglicéridos]]></kwd>
<kwd lng="es"><![CDATA[primer nivel de atención]]></kwd>
<kwd lng="es"><![CDATA[Latinoamérica]]></kwd>
<kwd lng="en"><![CDATA[Dyslipidemia]]></kwd>
<kwd lng="en"><![CDATA[HDL]]></kwd>
<kwd lng="en"><![CDATA[cholesterol]]></kwd>
<kwd lng="en"><![CDATA[lipids]]></kwd>
<kwd lng="en"><![CDATA[triglycerides]]></kwd>
<kwd lng="en"><![CDATA[primary care level]]></kwd>
<kwd lng="en"><![CDATA[Latin America]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Furgione]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Sánchez]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Scott]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Luti]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Arraiz]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Bermúdez]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Dislipidemias primarias como factor de riesgo para la enfermedad coronaria]]></article-title>
<source><![CDATA[Rev Latinoam Hipertensión]]></source>
<year>2009</year>
<volume>4</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>18-25</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Pickels]]></surname>
<given-names><![CDATA[EG]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The ultracentrifuge practical aspects of the ultracentrifugal analysis of proteins]]></article-title>
<source><![CDATA[Chem Rev]]></source>
<year>1942</year>
<volume>30</volume>
<page-range>341-55</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Fredrickson]]></surname>
<given-names><![CDATA[DS]]></given-names>
</name>
<name>
<surname><![CDATA[Levy]]></surname>
<given-names><![CDATA[RI]]></given-names>
</name>
<name>
<surname><![CDATA[Lees]]></surname>
<given-names><![CDATA[RS]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Fat transport in lipoproteins an integrated approach to mechanisms and disorders]]></article-title>
<source><![CDATA[N Engl J Med]]></source>
<year>1967</year>
<volume>276</volume>
<page-range>34-42</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Friedewald]]></surname>
<given-names><![CDATA[WT]]></given-names>
</name>
<name>
<surname><![CDATA[Levy]]></surname>
<given-names><![CDATA[RI]]></given-names>
</name>
<name>
<surname><![CDATA[Fredrickson]]></surname>
<given-names><![CDATA[DS]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Estimation of the concentration of lowdensity lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge]]></article-title>
<source><![CDATA[Clin Chem]]></source>
<year>1972</year>
<volume>18</volume>
<page-range>499-502</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="">
<collab>Center for Disease Control and Prevention</collab>
<source><![CDATA[Heart Disease Facts. Heart Disease Statistics and Maps]]></source>
<year>2017</year>
<publisher-loc><![CDATA[Atlanta, Georgia ]]></publisher-loc>
</nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mensah]]></surname>
<given-names><![CDATA[GA]]></given-names>
</name>
<name>
<surname><![CDATA[Brown]]></surname>
<given-names><![CDATA[DW]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[An overview of cardiovascular disease burden in the United States]]></article-title>
<source><![CDATA[Health Aff (Millwood)]]></source>
<year>2007</year>
<volume>26</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>38-48</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Levenson]]></surname>
<given-names><![CDATA[JW]]></given-names>
</name>
<name>
<surname><![CDATA[Skerrett]]></surname>
<given-names><![CDATA[PJ]]></given-names>
</name>
<name>
<surname><![CDATA[Gaziano]]></surname>
<given-names><![CDATA[JM]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Reducing the global burden of cardiovascular disease the role of risk factors]]></article-title>
<source><![CDATA[P Rev Cardiol]]></source>
<year>2002</year>
<volume>5</volume>
<page-range>188-99</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Núñez]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Rojas]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Torres]]></surname>
<given-names><![CDATA[W]]></given-names>
</name>
<name>
<surname><![CDATA[González]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Mejías]]></surname>
<given-names><![CDATA[JC]]></given-names>
</name>
<name>
<surname><![CDATA[Olivar]]></surname>
<given-names><![CDATA[LC]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Características sociodemográficas asociadas a dislipidemia en el estudio de prevalencia de síndrome metabólico de Maracaibo, Venezuela]]></article-title>
<source><![CDATA[Rev Latinoam Hipertensión]]></source>
<year>2013</year>
<volume>8</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>77</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Isomaa]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Almgren]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Tuomi]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Forsén]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Lahti]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Nissén]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Cardiovascular morbidity and mortality associated with the metabolic syndrome]]></article-title>
<source><![CDATA[Diabetes Care]]></source>
<year>2001</year>
<volume>24</volume>
<page-range>683-9</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Brown]]></surname>
<given-names><![CDATA[CD]]></given-names>
</name>
<name>
<surname><![CDATA[Higgins]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Donato]]></surname>
<given-names><![CDATA[KA]]></given-names>
</name>
<name>
<surname><![CDATA[Rohde]]></surname>
<given-names><![CDATA[FC]]></given-names>
</name>
<name>
<surname><![CDATA[Garrison]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Obarzanek]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Body mass index and the prevalence of hypertension and dyslipidemia]]></article-title>
<source><![CDATA[Obesity Res]]></source>
<year>2000</year>
<volume>8</volume>
<page-range>600-19</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Onat]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Hergenc]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Sari]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Türkmen]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Can]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Sansoy]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Dyslipidemia hypertension distinctive features and cardiovascular risk in a prospective population-based study]]></article-title>
<source><![CDATA[Am J Hypertension]]></source>
<year>2005</year>
<volume>18</volume>
<page-range>409-16</page-range></nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ponte-Negretti]]></surname>
<given-names><![CDATA[CI]]></given-names>
</name>
<name>
<surname><![CDATA[Isea-Pérez]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Lanas]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Medina]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Gomez-Mancebo]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Morales]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Atherogenic Dyslipidemia in Latin America Prevalence, causes and treatment: Expert &amp; apos;s position paper made by The Latin American Academy for the Study of Lipids (ALALIP) Endorsed by the Inter-American Society of Cardiology (IASC), the South American Society of Cardiology (SSC), the Pan-American College of Endothelium (PACE), and the International Atherosclerosis Society (IAS)]]></article-title>
<source><![CDATA[Int J Cardiol]]></source>
<year>2017</year>
<volume>243</volume>
<page-range>516-22</page-range></nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lazo-Porras]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Bernabe-Ortiz]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Malaga]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Gilman]]></surname>
<given-names><![CDATA[RH]]></given-names>
</name>
<name>
<surname><![CDATA[Acuna-Villaorduña]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Cardenas-Montero]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Low HDL cholesterol as a cardiovascular risk factor in rural, urban, and rural-urban migrants PERU MIGRANT cohort study]]></article-title>
<source><![CDATA[Atherosclerosis]]></source>
<year>2016</year>
<volume>246</volume>
<page-range>36-43</page-range></nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Tóth]]></surname>
<given-names><![CDATA[PP]]></given-names>
</name>
<name>
<surname><![CDATA[Potter]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Ming]]></surname>
<given-names><![CDATA[EE]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Prevalence of lipid abnormalities in the United States The National Health and Nutrition Examination Survey 2003-2006]]></article-title>
<source><![CDATA[J Clin Lipidol]]></source>
<year>2012</year>
<volume>6</volume>
<page-range>325-30</page-range></nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="">
<source><![CDATA[CLSI H18-A4. Procedures for the Handling and Processing of Blood Specimens for Common. Laboratory Tests; Approved Guideline-Fourth Edition. CLSI document H18-A4. Clinical and Laboratory Standard Institute, 950 West Valley Road, Suite 2500]]></source>
<year>2007</year>
<publisher-loc><![CDATA[Wayne, Pennsylvania 19087, USA ]]></publisher-loc>
</nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Nikolac]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[&#352;upak-Smol&#269;i&#263;]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[&#352;imundi&#263;]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[&#262;elap]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Croatian Society of Medical Biochemistry and Laboratory Medicine: national recommendations for venous blood sampling]]></article-title>
<source><![CDATA[Biochem Med (Zagreb)]]></source>
<year>2013</year>
<volume>23</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>242-54</page-range></nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Moya-Salazar]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Pio-Davila]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Evaluation of inter-batch variability in establishing and quality control of glucose]]></article-title>
<source><![CDATA[Med Univ]]></source>
<year>2016</year>
<volume>18</volume>
<numero>71</numero>
<issue>71</issue>
<page-range>85-90</page-range></nlm-citation>
</ref>
<ref id="B18">
<label>18</label><nlm-citation citation-type="journal">
<collab>National Cholesterol Education Program Expert Panel on Detection. Evaluation.and Treatment of High Blood Cholesterol in Adults</collab>
<article-title xml:lang=""><![CDATA[Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final Report]]></article-title>
<source><![CDATA[Circulation]]></source>
<year>2002</year>
<volume>106</volume>
<page-range>3143-421</page-range></nlm-citation>
</ref>
<ref id="B19">
<label>19</label><nlm-citation citation-type="journal">
<collab>U.S. Preventive Services Task Force</collab>
<article-title xml:lang=""><![CDATA[Statin Use for the Primary Prevention of Cardiovascular Disease in Adults, US Preventive Services Task Force Recommendation Statement]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bibbins-Domingo]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Grossman]]></surname>
<given-names><![CDATA[DC]]></given-names>
</name>
<name>
<surname><![CDATA[Curry]]></surname>
<given-names><![CDATA[SJ]]></given-names>
</name>
<name>
<surname><![CDATA[Davidson]]></surname>
<given-names><![CDATA[KW]]></given-names>
</name>
<name>
<surname><![CDATA[Epling Jr]]></surname>
<given-names><![CDATA[JW]]></given-names>
</name>
</person-group>
<source><![CDATA[JAMA]]></source>
<year>2016</year>
<volume>316</volume>
<numero>19</numero>
<issue>19</issue>
<page-range>1997-2007</page-range></nlm-citation>
</ref>
<ref id="B20">
<label>20</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Canalizo-Miranda]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Favela-Pérez]]></surname>
<given-names><![CDATA[EA]]></given-names>
</name>
<name>
<surname><![CDATA[Salas-Anaya]]></surname>
<given-names><![CDATA[JA]]></given-names>
</name>
<name>
<surname><![CDATA[Gómez-Díaz]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Jara-Espino]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Torres-Arreola]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Clinical practice guidelines Diagnosis and treatment of dyslipidemia]]></article-title>
<source><![CDATA[Rev Med Inst Mex Seguro Soc]]></source>
<year>2013</year>
<volume>51</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>700-9</page-range></nlm-citation>
</ref>
<ref id="B21">
<label>21</label><nlm-citation citation-type="journal">
<collab>American Diabetes Association</collab>
<article-title xml:lang=""><![CDATA[Classification and Diagnosis of Diabetes]]></article-title>
<source><![CDATA[Diabetes Care]]></source>
<year>2017</year>
<volume>40</volume>
<numero>^s1</numero>
<issue>^s1</issue>
<supplement>1</supplement>
<page-range>S11-24</page-range></nlm-citation>
</ref>
<ref id="B22">
<label>22</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cook]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Weitzman]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Auinger]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Nguyen]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Dietz]]></surname>
<given-names><![CDATA[WH]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Prevalence of a metabolic syndrome phenotype in adolescents Findings from the third national health and nutrition examination survey, 1988-1994]]></article-title>
<source><![CDATA[Arch Pediatr Adolesc Med]]></source>
<year>2003</year>
<volume>157</volume>
<numero>8</numero>
<issue>8</issue>
<page-range>821-7</page-range></nlm-citation>
</ref>
<ref id="B23">
<label>23</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Medina-Lezama]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Zea-Diaz]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Morey-Vargas]]></surname>
<given-names><![CDATA[OL]]></given-names>
</name>
<name>
<surname><![CDATA[Bolaños-Salazar]]></surname>
<given-names><![CDATA[JF]]></given-names>
</name>
<name>
<surname><![CDATA[Muñoz-Atahualpa]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Postigo-MacDowall]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Prevalence of the metabolic syndrome in Peruvian Andean hispanics The PREVENCION study]]></article-title>
<source><![CDATA[Diabetes Res Clin Pract]]></source>
<year>2007</year>
<volume>78</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>270-81</page-range></nlm-citation>
</ref>
<ref id="B24">
<label>24</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Vinueza]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Boissonnet]]></surname>
<given-names><![CDATA[CP]]></given-names>
</name>
<name>
<surname><![CDATA[Acevedo]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Uriza]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Benitez]]></surname>
<given-names><![CDATA[FJ]]></given-names>
</name>
<name>
<surname><![CDATA[Silva]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Dyslipidemia in seven Latin American cities CARMELA study]]></article-title>
<source><![CDATA[Preventive Medicine]]></source>
<year>2010</year>
<volume>50</volume>
<page-range>106-11</page-range></nlm-citation>
</ref>
<ref id="B25">
<label>25</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Núñez-Robles]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Huapaya-Pizarro]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Torres-Lao]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Esquivel-León]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Suarez-Moreno]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Yasuda-Espinoza]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Prevalencia de factores de riesgo cardiovascular y riesgo metabólico en escolares, universitarios y mujeres de organizaciones sociales de base en distritos de Lima, Callao, La Libertad y Arequipa, Perú 2011]]></article-title>
<source><![CDATA[Rev Perú Med Exp Salud Publica]]></source>
<year>2014</year>
<volume>31</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>652-9</page-range></nlm-citation>
</ref>
<ref id="B26">
<label>26</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Márquez-Sandoval]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Macedo-Ojeda]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Viramontes-Hörner]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Fernández Ballart]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Salas Salvadó]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Vizmanos]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The prevalence of metabolic syndrome in Latin America a systematic review]]></article-title>
<source><![CDATA[Public Health Nutr]]></source>
<year>2011</year>
<volume>14</volume>
<numero>10</numero>
<issue>10</issue>
<page-range>1702-13</page-range></nlm-citation>
</ref>
<ref id="B27">
<label>27</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[García]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Solís]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Calderón]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Luque]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Neyra]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Manrique]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Prevalencia de diabetes mellitus y factores de riesgo relacionados en una población urbana]]></article-title>
<source><![CDATA[Rev Soc Peru Med Interna]]></source>
<year>2007</year>
<volume>20</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>90-4</page-range></nlm-citation>
</ref>
<ref id="B28">
<label>28</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Scheidt-Nave]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Du]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Knopf]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Schienkiewitz]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Ziese]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Nowossadeck]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Verbreitung von Fettstoffwechselstörungen bei Erwachsenen in Deutschland. Ergebnisse der Studie zur Gesundheit Erwachsener in Deutschland (DEGS1)]]></article-title>
<source><![CDATA[Bundesgesundheitsbl]]></source>
<year>2013</year>
<volume>56</volume>
<page-range>661-7</page-range></nlm-citation>
</ref>
<ref id="B29">
<label>29</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Beltrán-Sánchez]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Harhay]]></surname>
<given-names><![CDATA[MO]]></given-names>
</name>
<name>
<surname><![CDATA[Harhay]]></surname>
<given-names><![CDATA[MM]]></given-names>
</name>
<name>
<surname><![CDATA[McElligott]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Prevalence and Trends of Metabolic Syndrome in the Adult U S. Population, 1999-2010]]></article-title>
<source><![CDATA[J Am Coll Cardiol]]></source>
<year>2013</year>
<volume>62</volume>
<numero>8</numero>
<issue>8</issue>
<page-range>697-703</page-range></nlm-citation>
</ref>
<ref id="B30">
<label>30</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Martínez-Hernández]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Chávez-Aguirre]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Prevalencia y comorbilidad de dislipidemias en el primer nivel de atención]]></article-title>
<source><![CDATA[Rev Med Inst Mex Seguro Soc]]></source>
<year>2007</year>
<volume>45</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>469-75</page-range></nlm-citation>
</ref>
<ref id="B31">
<label>31</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Delisle]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Desilets]]></surname>
<given-names><![CDATA[MC]]></given-names>
</name>
<name>
<surname><![CDATA[Vargas]]></surname>
<given-names><![CDATA[ER]]></given-names>
</name>
<name>
<surname><![CDATA[Garrel]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Metabolic syndrome in three ethnic groups using current definitions]]></article-title>
<source><![CDATA[Appl physiology, Nutr metabolism Physiologie appliquee, Nutr metabolisme]]></source>
<year>2008</year>
<volume>33</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>356-60</page-range></nlm-citation>
</ref>
<ref id="B32">
<label>32</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Málaga]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Zevallos-Palacios]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Lazo]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Huayanay]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[elevada frecuencia de dislipidemia y glucemia basal alterada en una población peruana de altura]]></article-title>
<source><![CDATA[Rev Peru Med Exp Salud Publica]]></source>
<year>2010</year>
<volume>27</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>557-61</page-range></nlm-citation>
</ref>
<ref id="B33">
<label>33</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Schuster]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The GALAXY Program An Update on Studies Investigating Efficacy and Tolerability of Rosuvastatin for Reducing Cardiovascular Risk]]></article-title>
<source><![CDATA[Expert Rev Cardiovasc Ther]]></source>
<year>2007</year>
<volume>5</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>177-93</page-range></nlm-citation>
</ref>
<ref id="B34">
<label>34</label><nlm-citation citation-type="journal">
<collab>Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)</collab>
<article-title xml:lang=""><![CDATA[ESC/EAS Guidelines for the management of dyslipidaemias]]></article-title>
<source><![CDATA[European Heart J]]></source>
<year>2011</year>
<volume>32</volume>
<page-range>1769-818</page-range></nlm-citation>
</ref>
<ref id="B35">
<label>35</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Frieden]]></surname>
<given-names><![CDATA[TR]]></given-names>
</name>
<name>
<surname><![CDATA[Berwick]]></surname>
<given-names><![CDATA[DM]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The &amp;raquo;,» &amp;reg;,® &amp;sect;,§ &amp;shy;,­ &amp;sup1;,¹ &amp;sup2;,² &amp;sup3;,³ &amp;szlig;,ß &amp;THORN;,Þ &amp;thorn;,þ &amp;times;,× &amp;Uacute;,Ú &amp;uacute;,ú &amp;Ucirc;,Û &amp;ucirc;,û &amp;Ugrave;,Ù &amp;ugrave;,ù &amp;uml;,¨ &amp;Uuml;,Ü &amp;uuml;,ü &amp;Yacute;,Ý &amp;yacute;,ý &amp;yen;,¥ &amp;yuml;,ÿ &amp;para;,¶ Million Hearts &amp; quot; initiative-preventing heart attacks and strokes]]></article-title>
<source><![CDATA[N Engl J Med]]></source>
<year>2011</year>
<volume>365</volume>
</nlm-citation>
</ref>
</ref-list>
</back>
</article>
